Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jingzhou Natural Astaxanthin is a China-based microalgae biotechnology and nutraceutical manufacturer focused on natural astaxanthin derived from Haematococcus pluvialis. The company researches, produces, and sells algae-based astaxanthin ingredients and finished products, including softgels, water-soluble preparations, and oil formulations. It appears to operate large-scale cultivation and production facilities in Jingzhou, Hubei, and has emphasized commercialization of natural astaxanthin for human health products as well as feed-related applications. The company has collaborated with Chinese Academy of Sciences institutes on algal cultivation technology and has reported local R&D projects related to anti-atherosclerosis and antithrombotic effects of astaxanthin. It is best characterized as a commercial nutraceutical and specialty ingredient company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jingzhou Natural Astaxanthin.